123 related articles for article (PubMed ID: 29705)
21. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
Teng CT; Buchler B; Teng CS
Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
[No Abstract] [Full Text] [Related]
22. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
Sobolev AS; Rybalkin SD
Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
[TBL] [Abstract][Full Text] [Related]
23. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
24. Drosophila cyclic nucleotide phosphodiesterases.
Davis RL; Kauvar LM
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
[No Abstract] [Full Text] [Related]
25. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
[TBL] [Abstract][Full Text] [Related]
26. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
Sharma RV; Bhalla RC
Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
[No Abstract] [Full Text] [Related]
27. Regulation of cyclic nucleotide phosphodiesterase forms by serum and insulin in cultured fibroblasts.
Pledger WJ; Thompson WJ; Epstein PM; Strada SJ
J Cell Physiol; 1979 Sep; 100(3):497-507. PubMed ID: 226555
[TBL] [Abstract][Full Text] [Related]
28. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
Singh R; Shankar R
Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
[No Abstract] [Full Text] [Related]
29. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
[TBL] [Abstract][Full Text] [Related]
30. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
[TBL] [Abstract][Full Text] [Related]
31. Altered cyclic adenosine 3':5'-monophosphate metabolism and enzymatic profiles of a transplantable murine submaxillary gland carcinoma (myoepithelioma).
Malamud D; Irwin D
Cancer Res; 1978 Sep; 38(9):2945-9. PubMed ID: 209890
[No Abstract] [Full Text] [Related]
32. Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments.
Jackson BA; Edwards RM; Dousa TP
Kidney Int; 1980 Oct; 18(4):512-8. PubMed ID: 6164816
[No Abstract] [Full Text] [Related]
33. Genetic analysis of cyclic nucleotide phosphodiesterases in S49 mouse lymphoma cells.
Bourne HR; Brothers VM; Kaslow HR; Groppi V; Walker N; Steinberg F
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():185-94. PubMed ID: 6326523
[No Abstract] [Full Text] [Related]
34. Theoretical analyses of the functioning of the high- and low-Km cyclic nucleotide phosphodiesterases in the regulation of the concentration of adenosine 3',5'-cyclic monophosphate in animal cells.
Fell DA
J Theor Biol; 1980 May; 84(2):361-85. PubMed ID: 6251314
[No Abstract] [Full Text] [Related]
35. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
Manganiello V
Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
[No Abstract] [Full Text] [Related]
36. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Worby A; Mensah LM; Murray KJ
Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
[No Abstract] [Full Text] [Related]
37. [Adenyl cyclase and adenosine-3',5'-monophosphate phosphodiesteraze: their nature, properties and regulation].
Dumler IL; Etingof RN
Vopr Med Khim; 1976; 22(2):151-61. PubMed ID: 16391
[TBL] [Abstract][Full Text] [Related]
38. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
Liang CM; Liu YP; Chabner BA
Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
[No Abstract] [Full Text] [Related]
39. Purification and characterization of high-affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney.
Thompson WJ; Epstein PM; Strada SJ
Biochemistry; 1979 Nov; 18(23):5228-37. PubMed ID: 227451
[No Abstract] [Full Text] [Related]
40. Cyclic nucleotide phosphodiesterases of the renal cortex. Characterization of basal-lateral membrane activities.
Filburn CR; Liang CT; Sacktor B
J Membr Biol; 1977 Oct; 37(1):29-43. PubMed ID: 21299
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
